0
Study | ONLINE FIRST

CD200 Upregulation in Vascular Endothelium Surrounding Cutaneous Squamous Cell Carcinoma

Daniel A. Belkin, MD; Hiroshi Mitsui, MD, PhD; Claire Q. F. Wang, PhD; Juana Gonzalez, PhD; Shali Zhang, BA; Kejal R. Shah, MD; Israel Coats, BA; Mayte Suàrez-Fariñas, PhD; James G. Krueger, MD, PhD; Diane Felsen, PhD; John A. Carucci, MD, PhD
JAMA Dermatol. 2013;149(2):178-186. doi:10.1001/jamadermatol.2013.1609.
Text Size: A A A
Published online

Objective  To characterize the presence of CD200 and CD200 receptor (CD200R) in the human cutaneous squamous cell carcinoma (SCC) microenvironment and to define a possible role for the CD200 axis in immune evasion by SCC.

Design  Gene expression in SCC vs normal skin was studied. Laser capture microdissection was used to determine differential expression of CD200 in normal skin vs actinic keratosis vs SCC in situ vs invasive SCC. Immunofluorescence microscopy was used to define expression of CD200R on macrophages, myeloid dendritic cells, natural killer cells, and T cells in SCC vs normal skin. The effects of SCC supernatant on induction of CD200 in human blood endothelial cells was also examined.

Setting  Academic Medical Center with an established Section of Mohs and Dermatologic Surgery and an active Cutaneous Biology Research Program.

Participants  Surgical discard tissue from deidentified patients and samples of normal skin from healthy volunteers were used in this study.

Main Outcome Measures  Expression of CD200 on SCC-associated blood vessels; expression of CD200 receptor on SCC-associated macrophages and T cells; and induction of CD200 on endothelial cells by SCC supernatants.

Results  CD200 gene and message were upregulated in SCC stroma. Immunostaining revealed a higher number of CD200+ cells in SCC stroma than in normal dermis (180.8 cells/mm2 vs 24.6 cells/mm2) (P < .01). CD200 was further identified mainly on blood vessel endothelium in SCC. Tumor supernatant was able to induce CD200 expression on human dermal blood endothelial cells in culture. CD200R was identified on macrophages and dendritic cells in SCC microenvironment.

Conclusions  CD200 expression on local blood vessels may promote tumor progression by suppressing CD200R+ myeloid cells during diapedesis. These data highlight a previously unrecognized mechanism of immune evasion by SCC and may provide guidance for the development of targeted therapy.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Grahic Jump Location

Figure 1. Messenger RNA (mRNA) and protein expression of CD200 are significantly increased in the stromal regions of squamous cell carcinoma (SCC). A, Cells in the interstitium of SCC tumor nests (SCC stroma) had significantly greater mRNA expression of CD200 (adjusted to human acidic ribosomal protein [hARP], in log2 scale) compared with cells in normal reticular dermis (RD); the average in normal RD was adjusted to 1.0. B, There was very low expression of CD200 in normal skin. C, CD200 was expressed in the dermis adjacent to SCC but was not highly expressed in tumor nests. D, The numbers of CD200+ cells were quantified. There was a significant increase in CD200+ cells in SCC stroma compared with normal RD. Error bars indicate mean (SEM). AK indicates actinic keratosis; EPI, epidermis.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 2. The number of PAL-E+ structures that coexpress CD200 increases with increasing invasiveness of squamous cell carcinoma (SCC). A, Immunofluorescence showed little coexpression of CD200 (green, left upper panel) and PAL-E (red, right upper panel) in normal dermis (n = 5). (The bottom panels show the merged image where double positive cells are identified in yellow.) B, Some PAL-E+ cells coexpress CD200 in the stroma of SCC in situ (n = 5). C, Nearly all PAL-E+ cells coexpress CD200 in invasive SCC (n = 7). D, There was little coexpression of CD200 (green, left upper panel) and LYVE-1 (red, right upper panel) in normal dermis (n = 5). E, There was little coexpression of CD200 and LYVE-1 in the stroma of SCC in situ (n = 5). F, There was little coexpression of CD200 (green, left upper panel) and LYVE-1 (red, right upper panel) in invasive SCC (n = 5). Scale bars = 100 μm.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 3. CD200 expression is inducible on human dermal blood endothelial cells (HDBECs) in culture using tumor supernatants. A, When cultured for 12 hours in media containing tumor supernatant, HDBECs had significantly greater messenger RNA (mRNA) expression (adjusted to human acidic ribosomal protein [hARP], in log2 scale) than when cultured in media alone; media with 0.01–μg/mL lipopolysaccharide (LPS) was used as a positive control. Error bars indicate mean (SEM). B, When cultured for 36 hours in media containing tumor supernatant, HDBECs had greater CD200 surface expression than when cultured with media alone, as measured by mean fluorescence intensity. Error bars indicate mean (SEM). C, Superimposed histograms of fluorescence intensity of HDBECs from selected samples of media alone and tumor supernatant illustrate a shift toward greater surface expression.

Place holder to copy figure label and caption
Grahic Jump Location

Figure 4. CD200 expression is induced to a greater degree on CD34high human dermal blood endothelial cells (HDBECs) treated with tumor supernatant compared with CD34high HDBECs treated with normal skin supernatant. A, CD31+ HDBECs were further gated on CD34high populations and analyzed for the expression of CD200. The value 25.3 reflects 25.3% of all cells. B, Superimposed histograms of fluorescence intensity of CD34high HDBECs from selected samples of media plus lipopolysaccharide (LPS) (red), normal skin supernatant (blue), and squamous cell carcinoma (SCC) tumor supernatant (green) illustrate a stepwise shift toward greater surface expression of CD200. The orange line indicates background fluorescence intensity (FMO). C, When cultured for 36 hours in media containing tumor supernatant, HDBECs were found to have greater CD200 surface expression than when cultured with normal skin supernatant, as measured by mean fluorescence intensity (MFI). Error bars indicate mean (SEM).

Place holder to copy figure label and caption
Grahic Jump Location

Figure 5. CD200 receptor (CD200R) is located on most CD163+ macrophages and occasional CD11c+ dendritic cells in the squamous cell carcinoma (SCC) microenvironment. A, Immunofluorescence in invasive SCC shows that the majority of CD163+ cells (green, left upper panel) coexpress CD200R (red, right upper panel). (The bottom panels show the merged image where double positive cells are identified in yellow.) B, Some CD11c+ cells (red, left upper panel) coexpress CD200R (green, right upper panel). C, There was little coexpression of CD3 and CD200R in invasive SCC. D, There was little coexpression of CD207/Langerin and CD200R in invasive SCC. E, There was little coexpression of NKp46 and CD200R in invasive SCC. Scale bars = 100 μm.

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs